{"text": ["Novartis'", "Immunotherapy", "Fails", "in", "Late-Stage", "Skin", "Cancer", "Study"], "created_at": "2020-08-24 13:48:01"}
{"text": ["Novartis", "Skin", "Cancer", "Drug", "Combination", "Involving", "Spartalizumab", "Fails", "Clinical", "Trial"], "created_at": "2020-08-24 07:57:18"}
{"text": ["Novartis", "CEO", "says", "COVID-19", "makes", "valuing", "takeover", "targets", "tougher"], "created_at": "2020-08-24 07:18:55"}
{"text": ["Stocks", "-", "Europe", "Seen", "Higher", "Amid", "Virus", "Treatment", "Optimism"], "created_at": "2020-08-24 02:08:55"}
